Cerebrolysin
Porcine-brain peptide mixture — neurotrophic research, used clinically for stroke/dementia abroad.
- Half-life
- Not established
- Out of system
- —
- Route
- Intramuscular
- Level
- Advanced
What Cerebrolysin is used for
- Neurotrophic peptide mixture used clinically (outside the US) for stroke and dementia
- Reported cognition and recovery support in those settings
- Decades of use in some countries
How it's typically used
Clinical literature: ~5 mL intramuscular daily in 10–20 day courses.
What to watch for
- Derived from pig brain — allergy/contamination risk; sourcing matters
- Not FDA-approved; benefit in healthy adults is unproven
- Injectable course — sterile technique required
About Other research compounds
- What they are
- Nootropics, metabolic agents, and research compounds that don't fit the other classes.
- How they're run
- Route and schedule vary widely — check the individual entry.
- What to watch
- This is the least-characterised corner of the atlas. Read the full guide, and treat anything without published human data as exactly that.
Full guide
Cerebrolysin: A Tracking Guide and an Honest Look at the Evidence
What Cerebrolysin is, why the stroke evidence is genuinely mixed, and the metrics worth logging if you use it.
Other other research compounds
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.